This site is intended for:
katerzia logo mixed - landscape
katerzia logo mixed - landscape
A group of child hypertension patients wearing backpacks gather in a group together
Actor Portrayal

Ensuring Easy, Affordable Access 
to Katerzia Is Important to Us

Katerzia droplet bullet icon
Co-pay as low as $0* per prescription for most commercially insured patients
Katerzia droplet bullet icon
Discounts automatically applied at pharmacy with no cards, coupons, or apps required at participating pharmacies*
Katerzia droplet bullet icon
Because it is FDA-approved, Katerzia generally has broader coverage than compounded formulations, which are not FDA-approved prescription medicines
*Eligibility restrictions and terms and conditions may apply.
†Approximate participating pharmacies for eVoucherRx™ and Voucher on
 Demand™.

FDA=US Food and Drug Administration.
A purple map of the United States indicating that Katerzia is available in all 50 states

Katerzia is available at more than 70,000 local pharmacies nationwide† for easy accessibility and is covered under commercial insurance and Medicaid in all 50 states.

*Eligibility restrictions and terms and conditions may apply.
†Approximate participating pharmacies for eVoucherRx™ and Voucher on Demand™.

FDA=US Food and Drug Administration.
Katerzia Icon Locator

Find a Local Pharmacy That Offers Automatic Katerzia Co-pay Discounts

Just enter your ZIP code in our pharmacy finder to see
all of the pharmacies near you that participate in the Katerzia automatic discount program.
Search Now
Katerzia icon mail

Stay Up to Date on the Latest 
News About Katerzia

Sign up here to join fellow patients, parents, and providers on our secure mailing list for news and updates relating to Katerzia and pediatric hypertension.
Sign Up
A doctor consults with a smiling young patient who is experiencing pediatric hypertension
Actor Portrayal

For Coverage Questions, We Have You Covered

Azurity Solutions is designed to help you get the Azurity Pharmaceuticals medications your doctor prescribes.

Katerzia droplet bullet icon
Ensuring that low, discounted co-pays for Azurity Pharmaceuticals medicines are automatically applied and that no co-pay cards are needed at more than 70,000 participating pharmacies nationwide*,†
Katerzia droplet bullet icon
Securing coverage by Medicaid plans in all 50 states and most 
commercial health insurance plans
Katerzia droplet bullet icon
Working behind the scenes with your provider to overcome obstacles to access
Katerzia droplet bullet icon
The Bridge Drug Program provides up to 30 days of drug when insurance approvals are delayed for qualifying patients†
Katerzia droplet bullet icon
Additional need-based assistance is available for uninsured patients†
*Approximate participating pharmacies for eVoucherRx™ and Voucher on Demand™.
†Eligibility restrictions and terms and conditions may apply.
divider droplet icon
A pharmacist talks to a mother and her young daughter about filling a Katerzia prescription
Actor Portrayal
azurity solutions patient support logo

Need more help? Patient Assistance is here.

Your access to Katerzia shouldn’t be limited by your ability to pay. The Azurity Solutions Patient Assistance Program helps eligible patients get the financial support they need.

Learn More
divider droplet icon

Resources

What Industry Professionals Have to Say

Katerzia Icon Article
Factors That Can Affect Adherence to Oral Liquid Medications
This article from a leading journal for pharmacists discusses the reasons why patients of different ages do not take medications as prescribed.
Read Now
Katerzia Icon Video
Benefits of Liquid Formulations in Pediatric Patients
Bonnie Smeryage, a nurse practitioner in a busy pediatric nephrology practice, discusses the need for alternative drug delivery options in younger patients and the role that liquid formulations play for the patients and families she sees.
Watch Now
Katerzia Icon Video
Liquid Medications Are Convenient to Titrate and Change Doses
In this video, Bonnie Smeryage, nephrology nurse practitioner, explains how liquid formulations allow her to work with parents to titrate and adjust dosing without the need for additional office visits or new prescriptions.
Watch Now
Katerzia Icon Video
Patients Are Comfortable Using Liquid Medications
Nurse practitioner Bonnie Smeryage explains the value that liquid formulations play in ensuring that parents of pediatric patients understand how a drug is to be delivered and feel confident in their ability to dose as directed.
Watch Now
Katerzia Icon Video
Pediatric Patient Adherence and Blood Pressure Medication
With increasing attention being paid to patient compliance in the management of pediatric hypertension, nurse practitioner Bonnie Smeryage explains how her busy nephrology practice relies on liquid formulations for both children and teens.
Watch Now
divider droplet icon

Did you know that Azurity Pharmaceuticals offers many FDA-approved liquid formulations? Visit Azurity.com to learn more.

Go Now

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.
Product labeling, packaging, and imagery are for representation purposes only.

Healthcare provider and patient images on this website are not actual healthcare providers and patients.

The Information contained herein, including product information, is intended only for residents of the United States.

© 2024 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners.
PP-KAT-US-0059

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

See More

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.